Diabetes UK Annual Professional Conference, Birmingham Estimating risk of clinically evident neuropathy in type 2 diabetes: a UKPDS risk equation
Coleman RL, Stevens RJ, Holman RR
Diabetic Medicine 2006;23:Suppl. 2:51
66th Scientific Session of the American Diabetes Association, Washington Estimating Risk of Clinically Evident Retinopathy in Type 2 Diabetes.
Coleman RL, Stevens RJ, Aldington SJ, Holman RR
Diabetes 2006;55:Suppl 1:A53
27th Annual Conference of The International Society for Clinical Biostatistics, Geneva Nonparametric regression techniques for inference in highly skewed quality of life data - a case study with LDS diabetes patients using sf-36 scores
Paul SK, Holman RR
ISCB2006 Abstract Book 2006;215
Diabetes UK Annual Professional Conference, Birmingham Treating to target in Type 2 diabetes (4-T) study of analogue insulin initiation and titration
Farmer AJ, Thorne KA, Stratton IM, Davies M, Keenan J, Teo E, Levy J, Holman RR
Diabetic Medicine 2006;23:Suppl 2:85 [Abstract]
Diabetes UK Annual Professional Conference, Birmingham LDL cholesterol levels alone do not adequately assess coronary heart disease risk in Type 2 diabetes
Farmer AJ, Paul S, Stratton IM, Tucker L, Neil HAW, Holman RR
Diabetic Medicine 2006;23:Suppl 2:89 [Abstract]
66th Scientific Session of the American Diabetes Association, Washington LDL Cholesterol Level Alone does not Assess Coronary Heart Disease Risk Adequately in Type 2 Diabetes
Farmer AJ, Paul SK, Stratton IM, Tucker L, Neil AW and Holman RR
Diabetes 2006;55:Suppl 1:A462 [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk